TRVI vs. ARKF
TRVI (Trevi Therapeutics, Inc.) is a stock, while ARKF (ARK Fintech Innovation ETF) is Blockchain fund actively managed by ARK. Over the past 5 years, TRVI returned 52.85%/yr vs -4.30%/yr for ARKF. At a 0.20 correlation, their price movements are largely independent.
Performance
TRVI vs. ARKF - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, TRVI achieves a 31.95% return, which is significantly higher than ARKF's -13.25% return.
TRVI
- 1D
- -7.40%
- 1M
- 16.26%
- 6M
- 46.32%
- YTD
- 31.95%
- 1Y
- 152.21%
- 3Y*
- 97.02%
- 5Y*
- 52.85%
- 10Y*
- —
ARKF
- 1D
- -0.74%
- 1M
- 6.19%
- 6M
- -16.15%
- YTD
- -13.25%
- 1Y
- -18.91%
- 3Y*
- 20.97%
- 5Y*
- -4.30%
- 10Y*
- —
TRVI vs. ARKF - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
TRVI Trevi Therapeutics, Inc. | 31.95% | 203.88% | 207.46% | -30.57% | 146.74% | -67.68% | -35.47% | -60.53% |
ARKF ARK Fintech Innovation ETF | -13.25% | 28.67% | 34.34% | 93.27% | -65.07% | -17.82% | 108.03% | 6.91% |
Correlation
The correlation between TRVI and ARKF is 0.23, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.23 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.22 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.24 |
Correlation (All Time) Calculated using the full available price history since May 7, 2019 | 0.20 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TRVI vs. ARKF — Risk / Return Rank
TRVI
ARKF
TRVI vs. ARKF - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Trevi Therapeutics, Inc. (TRVI) and ARK Fintech Innovation ETF (ARKF). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| TRVI | ARKF | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +3.04 | ||
| Sortino ratioReturn per unit of downside risk | +3.52 | ||
| Omega ratioGain probability vs. loss probability | 1.38 | 0.93 | +0.45 |
| Calmar ratioReturn relative to maximum drawdown | 5.19 | -0.49 | +5.68 |
| Martin ratioReturn relative to average drawdown | 12.24 | -0.83 | +13.07 |
Loading charts...
Drawdowns
TRVI vs. ARKF - Drawdown Comparison
The maximum TRVI drawdown since its inception was -95.45%, which is greater than ARKF's maximum drawdown of -78.63%. Use the drawdown chart below to compare losses from any high point for TRVI and ARKF.
Loading charts...
Drawdown Indicators
| TRVI | ARKF | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -95.45% | -78.63% | -16.82% |
Max Drawdown (1Y)Largest decline over 1 year | -29.50% | -38.50% | +9.00% |
Max Drawdown (3Y)Largest decline over 3 years | -56.88% | -38.50% | -18.38% |
Max Drawdown (5Y)Largest decline over 5 years | -78.10% | -75.30% | -2.80% |
Current DrawdownCurrent decline from peak | -15.28% | -34.97% | +19.69% |
Average DrawdownAverage peak-to-trough decline | -60.87% | -34.97% | -25.90% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 12.49% | 22.71% | -10.22% |
Volatility
TRVI vs. ARKF - Volatility Comparison
Trevi Therapeutics, Inc. (TRVI) has a higher volatility of 18.60% compared to ARK Fintech Innovation ETF (ARKF) at 8.81%. This indicates that TRVI's price experiences larger fluctuations and is considered to be riskier than ARKF based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| TRVI | ARKF | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 18.60% | 8.81% | +9.79% |
Volatility (6M)Calculated over the trailing 6-month period | 40.16% | 25.64% | +14.52% |
Volatility (1Y)Calculated over the trailing 1-year period | 61.86% | 33.71% | +28.15% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 88.36% | 42.98% | +45.38% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 99.05% | 39.68% | +59.37% |
Dividends
TRVI vs. ARKF - Dividend Comparison
TRVI has not paid dividends to shareholders, while ARKF's dividend yield for the trailing twelve months is around 0.10%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
ARKF ARK Fintech Innovation ETF | 0.10% | 0.09% | 0.00% | 0.00% | 0.00% | 0.00% | 0.37% | 1.25% |
TRVI Trevi Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
TRVI and ARKF have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
TRVI has higher volatility (18.60%) compared to ARKF (8.81%). In terms of maximum drawdown, TRVI dropped -95.45% vs ARKF's -78.63%.
TRVI currently has the higher Sharpe Ratio (2.48 vs -0.56), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for TRVI and ARKF
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer